You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 14, October 8, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  PRELIMINARY COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (126)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intractable Rheumatoid Arthritis

Treatment With Combined Cyclophosphamide, Azathioprine, and Hydroxychloroquine

Daniel J. McCarty, MD; Guillermo F. Carrera, MD

JAMA. 1982;248(14):1718-1723.


Abstract

Seventeen patients (15 women, two men) with progressive, erosive seropositive rheumatoid arthritis (RA) refractory to conventional therapy were treated with cyclophosphamide, azathioprine, and hydroxychloroquine sulfate for an average of 27 ± 19 months (x±SD throughout) (range, five to 60 months). Disease suppression began in 14 patients within three to 16 months (mean, seven months). Five patients achieved complete remission, two had activity in a single joint only, seven had partial disease suppression, and three showed no response. Prednisone dosage was decreased or administration discontinued in nine of ten patients (5.8 ±1.2 to 2.7 ±3 mg/day). Serial hand roentgenograms showed recortication of erosions in nine patients, with "filling in" of some erosions in three of these. No change was seen in the roentgenograms of five patients, while progressive disease occurred in three instances. Combined therapy with small doses of three drugs, each with proved antirheumatic activity when used separately in larger doses, may provide satisfactory long-term disease control in patients with intractable RA. This regimen is experimental. Proof of efficacy requires a controlled study. Until such data are obtained, this drug combination is not recommended for general use.

(JAMA 1982;248:1718-1723)



Author Affiliations

From the Rheumatology Section, Department of Medicine (Dr McCarty), and the Skeletal Radiology Section, Department of Radiology (Dr Carrera), The Medical College of Wisconsin, Milwaukee.


Footnotes

Reprint requests to the Department of Medicine, Milwaukee County General Hospital, 8700 W Wisconsin Ave, Milwaukee, WI 53226 (Dr McCarty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Two is better than one? Combination therapy in rheumatoid arthritis
Choy
Rheumatology (Oxford) 2004;43:1205-1207.
FULL TEXT  

Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 review
Pincus et al.
Rheumatology (Oxford) 2002;41:1346-1356.
ABSTRACT | FULL TEXT  

What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease
McQueen et al.
Ann Rheum Dis 2001;60:859-868.
ABSTRACT | FULL TEXT  

Healing of erosions in rheumatoid arthritis
Sokka and Hannonen
Ann Rheum Dis 2000;59:647-649.
ABSTRACT | FULL TEXT  

The role of anti-malarials in rheumatoid arthritis -- the American experience
Khraishi and Singh
Lupus 1996;5:S41-S44.
ABSTRACT  

The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French Experience
Kahan and Menkes
Lupus 1996;5:S45-S49.
ABSTRACT  

The use of antimalarials in combination with other disease modifying agents in RA -- the British experience
Duncan and Capell
Lupus 1996;5:S50-S58.
ABSTRACT  

Treatment of Intractable Rheumatoid Arthritis With Combined Cyclophosphamide, Azathioprine, and Hydroxychloroquine: A Follow-up Study
Csuka et al.
JAMA 1986;255:2315-2319.
ABSTRACT  

Apheresis and Rheumatoid Arthritis
DECKER
ANN INTERN MED 1983;98:666-667.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.